Our current ongoing trials are as follows:

• PATCH 1 & 2 – Two randomised controlled trials to investigate whether prophylactic antibiotics can prevent further episodes of cellulitis (erysipelas) of the leg. (NOW CLOSED TO RECRUITMENT)
• BLISTER - A randomised controlled trial to compare the safety and effectiveness of doxycycline with prednisolone for initial treatment of bullous pemphigoid. 
• STOP GAP - A randomised controlled trial to test the hypothesis that ciclosporin is more effective than prednisolone for the oral therapy of pyoderma gangrenosum. 
• LIMIT I - This is study to determine whether imiquimod is a sufficiently effective treatment for lentigo maligna (CLOSED TO RECRUITMENT).

Adopted Studies:

• SINS - Surgery versus Imiquimod for Nodular and Superficial basal cell carcinoma.  This is a randomised controlled multi-centre phase III trial.  Recruitment is now complete with 501 participants.  Follow up visits are for three years with a five year recurrence check using GP and hospital notes.  Trial Manager - Mara Ozolins can be contacted on tel. 0115 8468624.